Cingulate Stock Analysis

Cingulate Stock Analysis Notes

The book value of the company was currently reported as 1.55. The company recorded a loss per share of 4.03. Cingulate had not issued any dividends in recent years. The entity had 1:12 split on the 9th of August 2024. Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficithyperactivity disorder. The company was founded in 2012 and is headquartered in Kansas City, Kansas. Cingulate operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. For more info on Cingulate please contact Shane PharmD at 913 942 2300 or go to https://www.cingulate.com.

Cingulate Investment Alerts

Cingulate Upcoming and Recent Events

Cingulate Largest EPS Surprises

View All Earnings Estimates

Cingulate Environmental, Social, and Governance (ESG) Scores

Cingulate Stock Institutional Investors

Note, although Cingulate's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Cingulate Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 22.8 M.

Cingulate Profitablity

Management Efficiency

Cingulate has return on total asset (ROA) of (1.1414) % which means that it has lost $1.1414 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.5806) %, meaning that it created substantial loss on money invested by shareholders. Cingulate's management efficiency ratios could be used to measure how well Cingulate manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.1. The current Return On Capital Employed is estimated to decrease to -1.66. At this time, Cingulate's Non Current Assets Total are most likely to decrease significantly in the upcoming years. The Cingulate's current Non Currrent Assets Other is estimated to increase to about 18.3 B, while Total Assets are projected to decrease to roughly 11.7 M.

Technical Drivers

As of the 26th of July, Cingulate shows the Mean Deviation of 3.18, risk adjusted performance of 0.1083, and Downside Deviation of 3.93. Cingulate technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Cingulate jensen alpha, as well as the relationship between the potential upside and skewness to decide if Cingulate is priced correctly, providing market reflects its regular price of 5.5 per share. Given that Cingulate has jensen alpha of 0.3852, we suggest you to validate Cingulate's prevailing market performance to make sure the company can sustain itself at a future point.

Cingulate Price Movement Analysis

Cingulate Insider Trading Activities

Cingulate Outstanding Bonds

Cingulate Predictive Daily Indicators

Cingulate Corporate Filings

Cingulate Forecast Models

Cingulate's time-series forecasting models are one of many Cingulate's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cingulate's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cingulate prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cingulate shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cingulate. By using and applying Cingulate Stock analysis, traders can create a robust methodology for identifying Cingulate entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cingulate analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cingulate analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Cingulate stock analysis indicators help investors evaluate how Cingulate stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cingulate shares will generate the highest return on investment. By understating and applying Cingulate stock analysis, traders can identify Cingulate position entry and exit signals to maximize returns.

When running Cingulate's price analysis, check to measure Cingulate's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cingulate is operating at the current time. Most of Cingulate's value examination focuses on studying past and present price action to predict the probability of Cingulate's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cingulate's price. Additionally, you may evaluate how the addition of Cingulate to your portfolios can decrease your overall portfolio volatility.